Neuromuscular involvement in nephrogenic systemic fibrosis

Journal of Clinical Neuromuscular Disease

Volumn 9, Issue 2, 2007, Pages 297-302

  Keyrouz, Salah ^a   Rudnicki, Stacy A ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Muscular diseases; Nephrogenic fibrosing dermopathy; Nephrogenic systemic fibrosis; Neuromuscular disease; Peripheral nervous system diseases

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DIALYSIS; DRUG UPTAKE; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; EPIDURAL ABSCESS; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; JOINT MOBILITY; KIDNEY FAILURE; KIDNEY TUBULE NECROSIS; MALE; MUSCLE BIOPSY; MUSCLE STRENGTH; MYOPATHY; NEPHROGENIC SYSTEMIC FIBROSIS; NEUROMUSCULAR DISEASE; NEUROPHYSIOLOGY; PARAPLEGIA; PATHOPHYSIOLOGY; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN FIBROSIS;

FEMALE; FIBROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEUROMUSCULAR DISEASES; NEUROMUSCULAR JUNCTION; SKIN DISEASES;

EID: 37349017956     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e31815a2f9b     Document Type: Article

References (15)

1. Cowper SE, Robin HS, Steinberg SM, et al. Scleromyxoedema-like cutaneous disease in renal-dialysis patients. Lancet. 2000;356:1000-1001.
2. Cowper SE, Su LD, Bhawan HS, et al. Nephrogenic fibrosing dermopathy. Am J Dermatopathol. 2001;23:383-393.
3. Cassis TB, Jackson JM, Sonnier GB, et al. Nephrogenic fibrosing dermopathy in a patient with acute renal failure never requiring dialysis. Int J Dermatol. 2006;45:56-59.
4. Ting WW, Stone MS, Madison KC, et al. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol. 2003;139:903-906.
5. Gibson SE, Farver CF, Prayson RA. Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature. Arch Pathol Lab Med. 2006;130:209-212.
6. Kucher C, Steere J, Elenitsas R, et al. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. J Am Acad Dermatol. 2006;54:S31-S34.
7. Levine JM, Taylor RA, Elman LB, et al. Involvement of skeletal muscle in dialysis-associated fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve. 2004;30:569-577.
8. Cowper SE. Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. Am J Kidney Dis. 2005;46:763-765.
9. Mackay-Wiggan JM, Cohen DF, Hardy MA, et al. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol. 2003;48:55-60.
10. Mendoza FA, Artlett CM, Sandorfi N, et al. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Sem Arthritis Rheum. 2006;35:238-249.
11. Rubin DI, Hermann RC. Electrophysiologic findings in amyloid myopathy. Muscle Nerve. 1999;22:355-359.
12. Cowper SE, Boyer PJ. Nephrogenic systemic fibrosis: an update. Curr Rheumatol Rep. 2006;8:151-157.
13. Public Health Advisory. Gadolinium-containing contrast agents for magnetic resonance imaging (MRI): Omniscan, Optimakr, Magnevist, ProHance, and MultiHance. Available at: www.fda.gov/cder/drug/adviosry/gadolinium_agents.htm. Accessed September 29, 2006.
14. Gilliet M, Cozzio A, Burg G, et al. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol. 2005;152:531-536.
15. Baron PW, Cantos K, Hillebrand DJ, et al. Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol. 2003:25:204-209.